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1. Introduction 
Over the last 5 decades, because of the revolution in recombinant DNA technology, site-
directed mutagenesis became one of the most powerful tools in molecular life sciences. Its 
power lies in the ability to manipulate a specific DNA sequence in a definable and often 
predetermined way. Subsequently, genetic changes are correlated with a change in 
phenotype. Hence, this method offers the possibility to test protein functions down to the 
individual amino acid level and to characterize single nucleotides within regulatory RNA 
and DNA elements. In addition, synthetic point mutagenesis makes it possible to test 
whether specific mutations in a gene are benign or detrimental and thus lead to disease or 
not, in a model organism (Smith, 1985). 
2. Point mutagenesis, a historical perspective 
During the 1920’s, Hermann Joseph Muller, was the first scientist to report the effects of 
mutagens on DNA. He demonstrated that there was a quantitative relation between the 
exposure to x-ray radiation and lethal mutations in Drosophila. He used this technique later on 
to create Drosophila mutants for his genetic research. Furthermore, he noted that x-rays could 
not only mutate genes in fruit flies but also have effects on the human genome (Crow, 2005). 
In 1941, Charlotte Auberauch demonstrated similar results as Muller using mustard gas as a 
mutagen in microbes and Drosophila. Within her studies several biological effects of 
mutations were described such as mosaicism and the heritability of mutations when 
occurring in the gametes (Sobels, 1975). 
In 1978, Hutchison et al. (Hutchison et al., 1978) were among the first to describe site-
directed mutagenesis using synthetic oligonucleotides. They demonstrated that a chemically 
synthesized oligonucleotide annealed to a phage genome could produce a specific mutation 
when incorporated in a closed circular phage genome by in vitro enzymatic reactions. The 
basic procedure was to use a mutation-bearing oligonucleotide as a primer for DNA 
polymerase to synthesize a mutant single-stranded genome. A ligase was included so that 
the newly elongated DNA strand was ligated into the circular vector (Smith, 1985; 
Hutchison et al., 1971; Hutchison et al., 1978). Later on, several other techniques were 
described, including site-directed mutagenesis of double-strand plasmid DNA vectors and 






downside of these site directed point mutagenesis techniques was that they were time-
consuming. In particular the introduction of the mutated target sequence into the 
appropriate plasmid vector systems required multiple time-consuming steps. Furthermore, 
designed mutations were often obtained at low frequencies (Ho et al., 1989). 
The development of the Polymerase Chain Reaction (PCR) technique by Mullis in 1983 
provided opportunities to resolve these drawbacks. PCR uses two synthetic 
oligonucleotides as primers to exponentially amplify a specific DNA sequence. The primers 
are complementary to the ends of the amplified DNA and are oriented in opposite 
directions. Exponential amplification of target DNA occurs in multiple cycles of DNA 
duplex denaturation, primer annealing to single strand DNA and annealed primer 
extension by DNA polymerase. PCR is familiar as a method for the detection of a specific 
DNA sequence (Bartlett et al., 2003). As exemplified below, this method is also commonly 
applied to modify DNA sequences by design, using protocols that are collectively known as 
PCR-mediated site-directed mutagenesis.  
3. Site-directed mutagenesis I: PCR synthesis of bacterial plasmid vectors 
Site-directed mutagenesis is an important method to investigate the relationship between a 
given gene and its function. The technique is based on hybridization of a synthetic DNA 
primer containing the desired point mutation(s) with single-stranded target DNA 
encompassing the gene of interest. The hybridized DNA primer is extended by a DNA 
polymerase creating double-stranded DNA that can eventually be transformed into a host 
cell and cloned (Carter, 1986). 
Over the years optimization has taken place, creating a rapid and simple to execute protocol 
to alter plasmid-borne genes with high fidelity in a specific and precise fashion in vitro.  
One of the first methods used mutagenic primers which, after PCR, incorporate point 
mutations close to the PCR fragment’s ends. After PCR amplification the PCR products had 
to be cleaved with restriction enzymes and inserted in place of the wild-type sequence in a 
bacterial plasmid vector. However, the above site directed point mutagenesis protocol was 
limited by the (non)availability of restrictions sites in the close vicinity of the DNA sequence 
to be mutated. Furthermore, wild-type clones were recovered at a high frequency, making it 
tedious to isolate the desired mutant clones (Kadowaki et al., 1989). Hemsley et al. (Hemsley 
et al., 1989) improved the protocol by using an adaptation of inverse PCR, amplifying the 
whole circular plasmid to incorporate mutations at any site of the plasmid without relying 
on restriction sites in the close vicinity. This approach was fast and simple, and only a small 
amount of plasmid template DNA was required. Still, after PCR, linear instead of circular 
mutated plasmid DNA was obtained and this was physically separated from the original 
plasmid and circularized by ligation before transformation in E. coli. Despite these 
improvements the frequency of transformed bacteria harboring the desired mutant plasmid 
was still relatively low (Hemsley et al., 1989). Furthermore, the rates of unwanted random 
base substitution in these PCR reactions varied according to the reaction conditions, the 
precise DNA sequence and the DNA polymerase that had been used. Optimization of DNA 
polymerase fidelity in several PCR applications reduced the error-rate and thereby 
increased efficiency. The 3’5’ exonuclease activity of proofreading DNA polymerases is 
one of the most important replication error correction mechanisms in vivo (Eckert et al., 
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1991). Where former studies used thermostable DNA polymerases without 3’5’ 
exonuclease activity, nowadays thermostable DNA polymerases with proofreading activity 
are included to reduce the error-rate. For PCR controlled mutagenesis a balance between 
proofreading and mutagenesis is sought so as to allow introduction of desired point 
mutations into the target DNA sequence but not other mismatches. Combining two different 
DNA polymerases not only reduced the random error-rate but also allowed efficient 
amplification of considerably longer PCR fragments. This led to the invention of ‘long-
distance PCR’ where fragments up to 40kb in length are amplified, solving some of the 
technical limitations ascribed to gene and plasmid size (Barnes, 1994). 
Current site-directed mutagenesis of plasmid-borne DNA sequences (eg. Figure 1) use two 
complementary mutagenic overlapping primers that bind to the two complementary 
sequences at the site of the desired mutation and amplify the entire plasmid. Mutated 
plasmids are created through heteroduplex formation between the wild type template and 
the mutation-bearing primers during the first PCR cycles, normally using a mixture of DNA 
polymerases with and without proofreading activity, where consecutive cycles realize 
amplification. Where former mutagenesis protocols had trouble separating the mutated 
plasmid from the original template, newly marketed techniques resolved this problem. 
Restriction enzymes, like DpnI (target sequence, 5'-GmeATC-3') are specific for methylated 
and hemimethylated E. coli DNA and will degrade the original plasmid by enzymatic 
digestion (Figure 1) (Fisher et al., 1997; Li et al., 2002). The mutant PCR products, however, 
will be preserved from cleavage because they are enzymatically synthesized in vitro using 
unmethylated adenosine, contrary to the original plasmid templates produced by E. coli 
which are methylated at every GATC palyndrome. Although after amplification by PCR the 
mutant plasmid DNA is not a pristine closed double stranded DNA plasmid, the presence of 
single strand nicks is not an obstacle for transformation in bacteria, indicating that 
endogenous bacterial enzymes repair the PCR products (Figure 1). Overall, this technology 
offers the possibility to easily engineer and obtain mutated cloned plasmids in a highly 
efficient fashion in less than one week (Aslam 2010). 
4. Site-directed mutagenesis II: Vector engineering via homologous 
recombination in bacteria 
A second modern point mutagenesis protocol relies on homologous recombination of PCR 
products in bacteria and was pioneered by the Stewart laboratory at the EMBL in the late 
1990s.  
Homologous recombination is a class of genetic recombination in which genetic information 
is exchanged between two identical or nearly identical DNA molecules. In eukaryotes 
homologous recombination is used to repair several types of DNA damage and it plays a 
vital role during meiosis, creating genetic diversity in sexually reproducing populations. In 
bacteria, the main function of homologous recombination is to rescue DNA replication forks 
that collapsed due to template strand DNA damage. Bacteriophages also code for 
homologous recombination enzymes, indicating that they employ homologous 
recombination to maintain themselves at some yet undetermined point of their life cycle. 
Furthermore, bacterial homologous recombination also occurs during conjugation when 
plasmid and/or chromosomal DNA is transferred between bacterial cells in a process called 







Fig. 1. Bacterial plasmid vector mutagenesis by PCR. A purified bacterial plasmid with the 
sequence to be mutated is amplified by two complementary PCR primers (black arrows) 
bearing the desired point mutation (indicated by a white star). The DpnI methylated-DNA-
specific restriction enzyme is then used to destroy the original bacterial DNA vector, leaving 
only the mutant PCR version of the plasmid intact (right hand side). Destruction of the 
original template greatly reduces the number of E. coli clones, most of which now harbour 
the desired mutant plasmid. 
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Recombinogenic engineering, also known as ‘recombineering’ exploits homologous 
recombination to modify a DNA molecule inside bacteria in a precise and specific manner 
(Figure 2). Modification of a DNA molecule is accomplished by generating a synthetic 
targeting DNA construct (e.g. by PCR amplification) containing two regions that are 
homologous to regions flanking the target site. The targeting construct is introduced into an 
appropriate bacterial host cell that already bears the locus to be modified. Homologous 
recombination factors first resect the double strand DNA ends of the targeting construct into 
3’ single strand DNAs that align the construct with the double strand target locus and then 
insert it there via DNA polymerization at the invading 3’ end, followed by resolution of the 
resulting Holliday junctions. This is the case for simple modifications, such as inserting or 
deleting a DNA sequence. In many cases a second recombination step is performed to 
remove the selectable and counter selectable gene (Figure 2). One major advantage of this 
technique is that the sequences of homology regions can be selected freely, so long as they 
are unique, which makes it possible to specifically alter DNA sequences in bacteria at almost 
any position. The second advantage of two step recombineering is that it is possible to 
design strategies whereby the resultant mutant DNA bears no sequence alterations other 
than the desired mutation (Muyrers et al., 2000a; 2001). 
 
Fig. 2. Bacterial artificial chromosome point mutagenesis Two PCR products, bearing ~ 50 
bp homology arms (gray and black boxes) are used in sequence to select bacteria 
harbouring, firstly a chromosome with the desired point mutation together with a 
selectable/counter selectable gene and secondly to remove the selectable/counter selectable 






Bacterial artificial chromosomes (BAC) are usually more than 100 kb large, rendering their 
ex-vivo manipulation exceedingly difficult, mainly because these giant DNA molecules tend 
to fragment through exposure to shearing forces typically associated with liquid solution 
manipulation. Because BACs are vectors that can carry very large inserts, they do offer the 
opportunity to manipulate complete mammalian genes because the genomic DNA inserts 
include gene promoters, exons, introns and regulatory regions. BACs thus provide a milieu 
to modify higher eukaryote chromosomal segments. Recombineering can be applied to 
introduce precise changes in the nucleotide sequence of BACs in bacteria via homologous 
recombination factors and to then transfer the engineered DNA back into a mammal. The 
first part of this procedure has been named ET recombination, as it precisely engineers 
BACs using the homologous recombination factors RecE and RecT enzymes of the RAC 
prophage or the equivalent Red and Red proteins of Lambda phage. RecT and Red are 
DNA strand annealing factors (Erler et al., 2009) whilst RecE and Red are their partner 
5′3′ exonucleases (Muyrers et al., 2000b). ET recombination relies on synthetic linear DNA 
fragments that contain at least 50 nucleotide long homology arms, which are normally 
generated by PCR, to mediate homologous recombination at the desired region on the target 
(BAC) DNA. The use of linear targeting DNA fragments increases the efficiency of gene 
modification significantly because double strand DNA ends are the actual substrates for the 
RecE and Red exonucleases. 
A two-step use of ET recombination was developed to create subtle changes in DNA in 
bacteria, such as point mutations. The two-step protocol is based on a fusion protein that 
permits selection as well as counter selection. Hence, mutagenesis is divided in a selection 
and a counter selection step. In the first step, PCR is applied to create a linear DNA 
fragment containing the (counter)selectable fusion gene, the desired point mutation and 50 
nucleotide homology arms identical to the target DNA (Figure 2). Once that is successfully 
introduced by ET recombination, a second PCR fragment containing the original sequence 
of the BAC region and the desired point mutation is introduced into competent bacteria. 
This second PCR product enables a homologous recombination event that precisely deletes 
the counterselectable marker. The bacteria with the desired mutation are then selected by 
killing all the bacteria that still harbor the counterselectable gene. This two-step ET 
recombination can be applied to introduce single nucleotide substitutions as well as 
kilobase-sized insertions or deletions at any position in a desired locus encompassed by a 
BAC. Site-directed mutagenesis can also be performed on the actual bacterial chromosome, 
on BACs as exemplified here, or on any other double stranded DNA that is stably 
propagated in bacteria (Muyrers et al., 2001). 
5. Conclusion 
Over the years site-directed mutagenesis became an important tool to specifically mutate 
DNA molecules by design. Multiple studies contributed to the development of several 
techniques that can incorporate different kinds of mutations in rapid, simple and efficient 
ways. PCR fragment-mediated mutagenesis is one of these techniques. It permits efficient 
point mutagenesis of genes borne on plasmid vectors. On the other hand, combining PCR 
with recombineering in bacteria results in methodologies that can be applied to modify 
megabase-sized DNA fragments borne on artificial bacterial chromosomes, relying on the 
high fidelity associated with in vivo DNA replication. Subsequent transfer of such modified 
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BAC DNA into mice makes it possible to study the consequences of subtle chromosomal 
alterations, down to single nucleotide changes, within the native chromosomal 
environment. Application of these techniques on a large scale is leading to a better 
fundamental understanding of biology and disease aetiology (Skarnes et al., 2011) as well as 
providing opportunities to improve on what nature has offered to date. 
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